Cargando…
Cell Death-Related Ubiquitin Modifications in Inflammatory Syndromes: From Mice to Men
Aberrant cell death can cause inflammation and inflammation-related diseases. While the link between cell death and inflammation has been widely established in mouse models, evidence supporting a role for cell death in the onset of inflammatory and autoimmune diseases in patients is still missing. I...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219782/ https://www.ncbi.nlm.nih.gov/pubmed/35740456 http://dx.doi.org/10.3390/biomedicines10061436 |
_version_ | 1784732204388057088 |
---|---|
author | Peltzer, Nieves Annibaldi, Alessandro |
author_facet | Peltzer, Nieves Annibaldi, Alessandro |
author_sort | Peltzer, Nieves |
collection | PubMed |
description | Aberrant cell death can cause inflammation and inflammation-related diseases. While the link between cell death and inflammation has been widely established in mouse models, evidence supporting a role for cell death in the onset of inflammatory and autoimmune diseases in patients is still missing. In this review, we discuss how the lessons learnt from mouse models can help shed new light on the initiating or contributing events leading to immune-mediated disorders. In addition, we discuss how multiomic approaches can provide new insight on the soluble factors released by dying cells that might contribute to the development of such diseases. |
format | Online Article Text |
id | pubmed-9219782 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92197822022-06-24 Cell Death-Related Ubiquitin Modifications in Inflammatory Syndromes: From Mice to Men Peltzer, Nieves Annibaldi, Alessandro Biomedicines Review Aberrant cell death can cause inflammation and inflammation-related diseases. While the link between cell death and inflammation has been widely established in mouse models, evidence supporting a role for cell death in the onset of inflammatory and autoimmune diseases in patients is still missing. In this review, we discuss how the lessons learnt from mouse models can help shed new light on the initiating or contributing events leading to immune-mediated disorders. In addition, we discuss how multiomic approaches can provide new insight on the soluble factors released by dying cells that might contribute to the development of such diseases. MDPI 2022-06-17 /pmc/articles/PMC9219782/ /pubmed/35740456 http://dx.doi.org/10.3390/biomedicines10061436 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Peltzer, Nieves Annibaldi, Alessandro Cell Death-Related Ubiquitin Modifications in Inflammatory Syndromes: From Mice to Men |
title | Cell Death-Related Ubiquitin Modifications in Inflammatory Syndromes: From Mice to Men |
title_full | Cell Death-Related Ubiquitin Modifications in Inflammatory Syndromes: From Mice to Men |
title_fullStr | Cell Death-Related Ubiquitin Modifications in Inflammatory Syndromes: From Mice to Men |
title_full_unstemmed | Cell Death-Related Ubiquitin Modifications in Inflammatory Syndromes: From Mice to Men |
title_short | Cell Death-Related Ubiquitin Modifications in Inflammatory Syndromes: From Mice to Men |
title_sort | cell death-related ubiquitin modifications in inflammatory syndromes: from mice to men |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219782/ https://www.ncbi.nlm.nih.gov/pubmed/35740456 http://dx.doi.org/10.3390/biomedicines10061436 |
work_keys_str_mv | AT peltzernieves celldeathrelatedubiquitinmodificationsininflammatorysyndromesfrommicetomen AT annibaldialessandro celldeathrelatedubiquitinmodificationsininflammatorysyndromesfrommicetomen |